Abstract
The brain σ-1 receptors can bind neurosteroids and psychotropic drugs, including neuroleptics and cocaine and are implicated in schizophrenia, depression, and drug dependence. In this study, we found that σ-1 receptors specifically target lipid storage sites (lipid droplets) on the endoplasmic reticulum by forming a distinct class of lipid microdomains. Both endogenously expressing σ-1 receptors and transfected C-terminally enhanced yellow fluorescent protein (EYFP)-tagged σ-1 receptors (Sig-1R-EYFP) target unique “ring-like” structures associated with endoplasmic reticulum reticular networks in NG108-15 cells. The ring-like structures contain neutral lipids and are enlarged by the oleate treatment, indicating that they are endoplasmic reticulum-associated lipid droplets (ER-LDs). σ-1 receptors colocalize with caveolin-2, a cholesterol-binding protein in lipid rafts on the ER-LDs, but not with adipocyte differentiation-related protein (ADRP), a cytosolic lipid droplet (c-LD)-specific protein. When the double-arginine ER retention signal on the N terminus of σ-1 receptors is truncated, σ-1 receptors no longer exist on ER-LDs, but predominantly target c-LDs, which contain ADRP. σ-1 receptors on ER-LDs form detergent-resistant raft-like lipid microdomains, the buoyancy of which is different from that of plasma membrane lipid rafts. (+)-Pentazocine causes σ-1 receptors to disappear from the microdomains. N-Terminally EYFP-tagged σ-1 receptors (EYFP-Sig-1R) failed to target ER-LDs. EYFP-Sig-1R-transfected cells showed an unrestricted distribution of neutral lipids all over the endoplasmic reticulum network, decreases in c-LDs and cholesterol in plasma membranes, and the bulbous aggregation of endoplasmic reticulum. Thus, σ-1 receptors are unique endoplasmic reticulum proteins that regulate the compartmentalization of lipids on the endoplasmic reticulum and their export from the endoplasmic reticulum to plasma membrane and c-LDs.
Footnotes
-
This study was supported by the Intramural Research Program of National Institute on Drug Abuse, National Institutes of Health.
-
DOI: 10.1124/jpet.103.051284.
-
ABBREVIATIONS: ER-LD, endoplasmic reticulum-associated lipid droplet; c-LD, cytosolic lipid droplet; CYP450R, NADPH-cytochrome P450 reductase; CTx-B, cholera toxin subunit-B; GFP, green fluorescent protein; HBSS, Hanks' balanced salt solution; PBS, phosphate-buffered saline; EYFP, enhanced yellow fluorescent protein; EYFP-Sig-1R, N-terminally EYFP-tagged σ-1 receptor; Sig-1R-EYFP, C-terminally EYFP-tagged σ-1 receptor; ADRP, adipocyte differentiation-related protein; Cav, caveolin.
- Received March 5, 2003.
- Accepted April 29, 2003.
- The American Society for Pharmacology and Experimental Therapeutics
JPET articles become freely available 12 months after publication, and remain freely available for 5 years.Non-open access articles that fall outside this five year window are available only to institutional subscribers and current ASPET members, or through the article purchase feature at the bottom of the page.
|